Cargando…

Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics

BACKGROUND: Opioid use is well documented in several countries: some countries struggle with overuse, whereas others have almost no access to opioids. For Europe, limited data are available. This study analysed Hungarian opioid utilization in ambulatory care between 2006 and 2020. METHODS: We obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Engi, Zsófia, Benkő, Ria, Soós, Gyöngyvér, Szok, Délia, Csenki, Melinda, Csüllög, Emese, Balog, Attila, Csupor, Dezső, Viola, Réka, Doró, Péter, Matuz, Mária
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541344/
https://www.ncbi.nlm.nih.gov/pubmed/35848717
http://dx.doi.org/10.1002/ejp.2011
_version_ 1784803903617892352
author Engi, Zsófia
Benkő, Ria
Soós, Gyöngyvér
Szok, Délia
Csenki, Melinda
Csüllög, Emese
Balog, Attila
Csupor, Dezső
Viola, Réka
Doró, Péter
Matuz, Mária
author_facet Engi, Zsófia
Benkő, Ria
Soós, Gyöngyvér
Szok, Délia
Csenki, Melinda
Csüllög, Emese
Balog, Attila
Csupor, Dezső
Viola, Réka
Doró, Péter
Matuz, Mária
author_sort Engi, Zsófia
collection PubMed
description BACKGROUND: Opioid use is well documented in several countries: some countries struggle with overuse, whereas others have almost no access to opioids. For Europe, limited data are available. This study analysed Hungarian opioid utilization in ambulatory care between 2006 and 2020. METHODS: We obtained national drug utilization data on reimbursed opioid analgesics (ATC code: N02A) from a national health insurance database for a 15‐year period. We investigated utilization trends, using three volume‐based metrics [defined daily dose per 1000 inhabitants per day (DID), oral morphine equivalent per 1000 inhabitants per day, packages dispensed per 1000 inhabitants per year]. We stratified data based on administration routes, analgesic potency and reimbursement categories. RESULTS: Total opioid utilization increased during the study period according to all three metrics (74% in DID) and reached 5.31 DID by 2020. Upward trends were driven by an increase both in weak and strong opioid use (79% vs. 53%). The most commonly used opioids were fentanyl (in the strong category; 0.76 DID in 2020) and tramadol (in the weak category; 2.62 DID in 2020). Overall, tramadol was also the most commonly used opioid throughout the study period. Oral administration of opioid medications was dominant. Based on reimbursement categories, musculoskeletal pain was becoming a more frequent indication for opioid use (1552% increase in DID), while opioid use for cancer pain declined significantly during the study period (−33% in DID). CONCLUSIONS: Our low utilization numbers might indicate underuse of opioid analgesia, especially for cancer pain. SIGNIFICANCE: This study was one of the recent opioid utilization studies using three volume‐based metrics, covering a long time period. To our knowledge, this was also the first national, population level study describing opioid utilization in Hungary. National opioid utilization data suggested not an overuse but rather an underuse of opioid analgesics in a developed, Central European country.
format Online
Article
Text
id pubmed-9541344
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95413442022-10-14 Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics Engi, Zsófia Benkő, Ria Soós, Gyöngyvér Szok, Délia Csenki, Melinda Csüllög, Emese Balog, Attila Csupor, Dezső Viola, Réka Doró, Péter Matuz, Mária Eur J Pain Original Articles BACKGROUND: Opioid use is well documented in several countries: some countries struggle with overuse, whereas others have almost no access to opioids. For Europe, limited data are available. This study analysed Hungarian opioid utilization in ambulatory care between 2006 and 2020. METHODS: We obtained national drug utilization data on reimbursed opioid analgesics (ATC code: N02A) from a national health insurance database for a 15‐year period. We investigated utilization trends, using three volume‐based metrics [defined daily dose per 1000 inhabitants per day (DID), oral morphine equivalent per 1000 inhabitants per day, packages dispensed per 1000 inhabitants per year]. We stratified data based on administration routes, analgesic potency and reimbursement categories. RESULTS: Total opioid utilization increased during the study period according to all three metrics (74% in DID) and reached 5.31 DID by 2020. Upward trends were driven by an increase both in weak and strong opioid use (79% vs. 53%). The most commonly used opioids were fentanyl (in the strong category; 0.76 DID in 2020) and tramadol (in the weak category; 2.62 DID in 2020). Overall, tramadol was also the most commonly used opioid throughout the study period. Oral administration of opioid medications was dominant. Based on reimbursement categories, musculoskeletal pain was becoming a more frequent indication for opioid use (1552% increase in DID), while opioid use for cancer pain declined significantly during the study period (−33% in DID). CONCLUSIONS: Our low utilization numbers might indicate underuse of opioid analgesia, especially for cancer pain. SIGNIFICANCE: This study was one of the recent opioid utilization studies using three volume‐based metrics, covering a long time period. To our knowledge, this was also the first national, population level study describing opioid utilization in Hungary. National opioid utilization data suggested not an overuse but rather an underuse of opioid analgesics in a developed, Central European country. John Wiley and Sons Inc. 2022-08-12 2022-10 /pmc/articles/PMC9541344/ /pubmed/35848717 http://dx.doi.org/10.1002/ejp.2011 Text en © 2022 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation ‐ EFIC ®. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Engi, Zsófia
Benkő, Ria
Soós, Gyöngyvér
Szok, Délia
Csenki, Melinda
Csüllög, Emese
Balog, Attila
Csupor, Dezső
Viola, Réka
Doró, Péter
Matuz, Mária
Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title_full Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title_fullStr Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title_full_unstemmed Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title_short Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
title_sort trends in opioid utilization in hungary, 2006–2020: a nationwide retrospective study with multiple metrics
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541344/
https://www.ncbi.nlm.nih.gov/pubmed/35848717
http://dx.doi.org/10.1002/ejp.2011
work_keys_str_mv AT engizsofia trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT benkoria trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT soosgyongyver trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT szokdelia trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT csenkimelinda trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT csullogemese trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT balogattila trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT csupordezso trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT violareka trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT doropeter trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics
AT matuzmaria trendsinopioidutilizationinhungary20062020anationwideretrospectivestudywithmultiplemetrics